Evaluation of the Performance of an Adhesive Strip
A Pilot Evaluation of Newly Developed Adhesives and How They Are Impacted by Output
1 other identifier
interventional
7
1 country
1
Brief Summary
This study investigated the performance of a new adhesive strip when impacted by output
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2018
CompletedFirst Submitted
Initial submission to the registry
January 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2018
CompletedFirst Posted
Study publicly available on registry
February 1, 2018
CompletedFebruary 1, 2018
January 1, 2018
12 days
January 15, 2018
January 31, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Trans epidermal water loss
trans epidermal water loss is a measure of the skins barrier function. There is always a oss of water from the skin due to evaporation. However, when the skin barrier is damaged this evaporation increases. Thus, trans epidermal water loss can be used to assess the skins barrier function
24 hours
Study Arms (1)
Test of new adhesive strip
EXPERIMENTALA new adhesive strip has been developed and will be tested in this investigation
Interventions
Eligibility Criteria
You may qualify if:
- Have given written informed consent
- Be at least 18 years of age and have full legal capacity
- Have had an ileostomy for more than one year
- Have intact skin on the area used in the evaluation
- Has an ileostomy with a diameter up to (≤) 35 mm
- Have a peristomal area accessible for application of test product (assessed by investigator)
You may not qualify if:
- Currently receiving or have within the past 2 month received radio- and/or chemotherapy
- Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
- Are pregnant or breastfeeding
- Having dermatological problems in the peristomal- or abdominal area (assessed by investigator)
- Participating in other interventional clinical investigations or have previously participated in this investigation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
Study Sites (1)
Coloplast A/S
Humlebæk, 3050, Denmark
Study Officials
- PRINCIPAL INVESTIGATOR
Lene F Nielsen
Head of the pre-clinical department
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2018
First Posted
February 1, 2018
Study Start
January 10, 2018
Primary Completion
January 22, 2018
Study Completion
January 22, 2018
Last Updated
February 1, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share